Dechra Pharmaceuticals Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 2,400

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 7

  • Investments
  • 29

Dechra Pharmaceuticals General Information

Description

Developer and manufacturer of pharmaceutical products intended for veterinary, animal health and welfare. The company specializes in making and marketing a range of products as well as training, support and information services, enabling its clients to get a sustainable improvement in global animal health and welfare.

Contact Information

Website
www.dechra.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 24 Cheshire Avenue
  • Cheshire Business Park, Lostock Gralam
  • Northwich CW9 7UA
  • England, United Kingdom
+44 01606
Primary Industry
Pharmaceuticals
Other Industries
Other Commercial Services
Vertical(s)
Manufacturing, Life Sciences
Former Stock Listing
DCHPF
Corporate Office
  • 24 Cheshire Avenue
  • Cheshire Business Park, Lostock Gralam
  • Northwich CW9 7UA
  • England, United Kingdom
+44 01606

Dechra Pharmaceuticals Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dechra Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dechra Pharmaceuticals‘s full profile, request access.

Request a free trial

Dechra Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of pharmaceutical products intended for veterinary, animal health and welfare. The company sp
Pharmaceuticals
Northwich, United Kingdom
2,400 As of 2024

Stockholm, Sweden
 

Vejle, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dechra Pharmaceuticals Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recipharm Private Equity-Backed Stockholm, Sweden
Ceva Animal Health Corporation Vejle, Denmark
DSM-Firmenich Corporation Kaiseraugst, Switzerland
Prondil Corporate Backed or Acquired Montevideo, Uruguay
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany
You’re viewing 5 of 18 competitors. Get the full list »

Dechra Pharmaceuticals Executive Team (18)

Name Title Board Seat
Ian Page Chief Executive Officer & Board Member
Jesper Nordengaard Chief Executive Officer
Paul Sandland Chief Financial Officer & Executive Director
Tony Griffin Managing Director & Board Member
Jamie Adams Chief Information Officer
You’re viewing 5 of 18 executive team members. Get the full list »

Dechra Pharmaceuticals Board Members (15)

Name Representing Role Since
Dechra Pharmaceuticals Chief Executive Officer & Board Member
Self Board Member
Self Board Member
Self Board Member
Dechra Pharmaceuticals Chief Financial Officer & Executive Director
You’re viewing 5 of 15 board members. Get the full list »

Dechra Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dechra Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dechra Pharmaceuticals‘s full profile, request access.

Request a free trial

Dechra Pharmaceuticals Investments & Acquisitions (29)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Akston Biosciences (Veterinary Insulin Programs in Beverly) 30-Jul-2024 Buildings and Property
Invetx 18-Jul-2024 Other Healthcare Technology Systems
STEM Animal Health 15-Apr-2024 Other Consumer Non-Durables
STEM Animal Health 12-Apr-2024 Other Consumer Non-Durables
Med-Pharmex 30-Aug-2022 Merger/Acquisition Other Commercial Products
You’re viewing 5 of 29 investments and acquisitions. Get the full list »

Dechra Pharmaceuticals Subsidiaries (9)

Company Name Industry Location Founded
STEM Animal Health Other Consumer Non-Durables Winnipeg, Canada 2020
Invetx Other Healthcare Technology Systems Boston, MA
RxVet Other Pharmaceuticals and Biotechnology Paraparaumu, New Zealand
AST Farma Other Consumer Non-Durables Oudewater, Netherlands
Le Vet. Beheer Other Financial Services Oudewater, Netherlands
You’re viewing 5 of 9 subsidiaries. Get the full list »

Dechra Pharmaceuticals ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

14.26 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,009

Rank

Percentile

Pharmaceuticals

Industry

of 909

Rank

Percentile

Pharmaceuticals

Subindustry

of 446

Rank

Percentile

To view Dechra Pharmaceuticals’s complete esg history, request access »

Dechra Pharmaceuticals FAQs

  • When was Dechra Pharmaceuticals founded?

    Dechra Pharmaceuticals was founded in 1997.

  • Who is the CEO of Dechra Pharmaceuticals?

    Ian Page and Jesper Nordengaard are the CEOs of Dechra Pharmaceuticals.

  • Where is Dechra Pharmaceuticals headquartered?

    Dechra Pharmaceuticals is headquartered in Northwich, United Kingdom.

  • What is the size of Dechra Pharmaceuticals?

    Dechra Pharmaceuticals has 2,400 total employees.

  • What industry is Dechra Pharmaceuticals in?

    Dechra Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Dechra Pharmaceuticals a private or public company?

    Dechra Pharmaceuticals is a Private company.

  • What is the current valuation of Dechra Pharmaceuticals?

    The current valuation of Dechra Pharmaceuticals is .

  • What is Dechra Pharmaceuticals’s current revenue?

    The current revenue for Dechra Pharmaceuticals is .

  • How much funding has Dechra Pharmaceuticals raised over time?

    Dechra Pharmaceuticals has raised $666M.

  • Who are Dechra Pharmaceuticals’s investors?

    Abu Dhabi Investment Authority and EQT have invested in Dechra Pharmaceuticals.

  • Who are Dechra Pharmaceuticals’s competitors?

    Recipharm, Ceva Animal Health, DSM-Firmenich, Prondil, and Boehringer Ingelheim are some of the 18 competitors of Dechra Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »